[1] LIU Q, ZHOU L, LI R. Research progress of sinomenine[J]. Chin Tradit Herb Drugs(中草药), 1997, 28(4):247-249.
[2] WANG Y, ZANG Y H. Clinical observation on the treatment of rheumatoid arthritis by acupoint injection of Zhengqingfengtongning[J]. China Naturopathy(中国民间疗法), 2018, 26(13):114-115.
[3] LI L, HE Z Y, LI X H, et al. Clinical observation of Zhengqingfengtongning acupoint transdermal therapy in treating chronic nephritis[J]. J Hunan Univ Chin Med(湖南中医药大学学报), 2015, 35(11):45-47,55.
[4] SI L L. To explore the clinical effect and mechanism of Zhengqingfengtongning tablets combined with Febuxosta in the treatment of gouty arthritis[J]. Cardio Dis J Integr Tradit Chin West Med(中西医结合心血管病电子杂志), 2018, 6(31):38.
[5] BI X Y, BAI R X. Clinical observation on 50 cases of rheumatoid arthritis and ankylosing spondylitis treated by Zhengqingfengtongning[J]. Chin Tradit Herb Drugs(中草药), 2000, 31(4):48-49.
[6] CAO J H, ZHAO G S, FENG Y J. Chemical constituents and pharmacological effects of sinomenia[J]. World Phyto Med(国外医药;植物药分册), 2008, 23(2):62-66.
[7] BAN X H, HUANG Z Y, LI Y, et al. Studies on the chemical constituents of sinomenia[J]. Lishizhen Med Mater Med Res(时珍国医国药), 2008, 19(8):1831-1832.
[8] HUANG Z Y, ZHANG Y H, ZHOU L, et al. Studies on the chemical constituents of sinomenia(Ⅱ)[J]. Chin Tradit Herb Drugs(中草药), 2009, 40(2):193-196.
[9] SONG S H, ZHANG Y H, HUANG Z Y. Study on alkaloids in sinomenia[J]. Lishizhen Med Mater Med Res(时珍国医国药), 2011, 22(2):327-328.
[10] WANG X L, LIU B R, WANG J R, et al. Two new morphinane alkaloids from Sinomenium acutum[J]. J Asian Nat Prod Res, 2011, 13(6):523-528.
[11] JIANG Z M, WANG L J, PANG H Q, et al. Rapid profiling of alkaloid analogues in Sinomenii Caulis by an integrated characterization strategy and quantitative analysis[J]. J Pharm Biomed Anal, 2019, 174(6):376-385.
[12] Ch.P(2015). VolⅠ(中国药典2015年版.一部)[S]. 2015:195.
[13] SHI D Z, FANG M Y, LI D L, et al. Study on the microscopic identification of commercial sinomenia[J]. Lishizhen Med Mater Med Res(时珍国医国药), 2018, 29(7):1647-1649.
[14] QU F L, DONG W S, LIU R, et al. Content comparison of sinomenine in Caulis Sinomenii from different habitats[J]. Chin Pharm(中国药业), 2010, 19(18):32-33.
[15] WANG Q Q, FANG M Y, LIU S Y, et al. Content assay of sinomenine and magnoflorine in commercial Caulis Sinomeni by HPLC[J]. Mod Chin Med(中国现代中药), 2018, 20(11):1367-1371.
[16] CHEN J, ZHAO L, ZHANG H, et al. Determination of sinomenine in sinomenine by nonaqueous capillary electrophoresis[J]. J Pharm Pract(药学实践杂志), 2009, 27(6):434-436.
[17] CHEN X, SHI S F. Determination of heavy metals and trace elements in the roots of Caulis sinomenii by AAS[J]. J Anhui Agric Sci(安徽农业科学), 2011, 39(18):10785-10786,10789.
[18] GAO T L, HAO J X, WIESENFELD H Z, et al. Analgesic effect of sinomenine in rodents after inflammation and nerve injury[J]. Eur J Pharmacol, 2013, 721(9):5-11.
[19] LI X, WEI Y X, XIE Z X, et al. Study on the anti-inflammatory and analgesic effects of sinomenine and its mechanism[J]. J Chin Med Mater(中药材), 2017, 40(10):2445-2448.
[20] ZHU Q, SUN Y, MAO L, et al. Antinociceptive effects of sinomenine in a rat model of postoperative pain[J]. Br J Pharmacol, 2016, 173(10):1693-1702.
[21] LEE J Y, YOON S Y, WON J H, et al. Sinomenine produces peripheral analgesic effects via inhibition of voltage-gated sodium currents[J]. Neuroscience, 2017, 358(6):28-36.
[22] ZHAN J, YANG L, YI G B, et al. Effects of sinomenine hydrochloride on the expressions of NF-κB, COX-2 and 5-HT in periaqueductal grey of rats with migraine[J]. Chin Tradit Pat Med(中成药), 2015, 37(10):2121-2126.
[23] SUN Y, YAO Y, DING C Z. A combination of sinomenine and methotrexate reduces joint damage of collagen induced arthritis in rats by modulating osteoclast-related cytokines[J]. Int Immunopharmacol, 2014, 18(1):135-141.
[24] JIANG C, TONG Y L, ZHANG D, et al. Sinomenine prevents the development of cardiomyopathy in diabetic rats by inhibiting inflammatory responses and blocking activation of NF-κB[J]. Gen Physiol Biophys, 2017, 36(1):65-74.
[25] SHI H, ZHENG K, SU Z L, et al. Sinomenine enhances microglia M2 polarization and attenuates inflammatory injury in intracerebral hemorrhage[J]. J Neuroimmunol, 2016, 299(8):28-34.
[26] ZHAO Z J, XIAO J, WANG J C, et al. Anti-inflammatory effects of novel sinomenine derivatives[J]. Int Immunopharmacol, 2015, 29(10):354-360.
[27] LIU Y, SUN Y S, ZHOU Y H, et al. Sinomenine hydrochloride inhibits the progression of plasma cell mastitis by regulating IL-6/JAK2/STAT3 pathway[J]. Int Immunopharmacol, 2019, 131(81):106025.
[28] WANG L J, JIANG Z M, XIAO P T, et al. Identification of anti-inflammatory components in Sinomenii Caulis based on spectrum-effect relationship and chemometric methods[J]. J Pharm Biomed Anal, 2019, 167(1):38-48.
[29] JIAO Z Z, AN M Z, FU H X, et al. The immunosuppressive effect of sinomenine on lymphocytes stimulated by allogeneic islets[J]. Chin J Transplant (Elec Ed)(中华移植杂志:电子版), 2018, 12(3):106-110.
[30] CHEN G X, WANG P X, LIU Q P, et al.Study on the mechanism of immunosuppression of sinomenine on collagen induced arthritis[J]. Current Immu(现代免疫学), 2008, 28(2):142-146.
[31] DAI Y B, HUANG X, LUO Z G, et al. Inhibitory effect of sinomenine on acute rejection reaction in renal transplantation of rats[J]. Chin J Mod Med(中国现代医学杂志), 2004, 14(11):49-54.
[32] CHEN Y W, LI J Y, ZHANG J B, et al. Sinomenine inhibits B7-H1 and B7-DC expression on human renal tubular epithelial cells[J]. Int Immunopharmacol, 2005, 5(3):1446-1457.
[33] SHU L, YIN W, ZHANG J, et al. Sinomenine inhibits primary CD4⁺ T-cell proliferation via apoptosis[J]. Cell Biol Int, 2007, 31(1):784-789.
[34] FU Y F, LI L, FANG P, et al. Sinomenine's protective role and mechanism in stress load-induced heart failure[J]. J Pharm Pharmacol, 2020, 72(2):209-217.
[35] WANG W Q, YANG X T, CHEN Q H, et al. Sinomenine attenuates septic-associated lung injury through the Nrf2-Keap1 and autophagy[J]. J Pharm Pharmacol, 2020, 72(2):259-270.
[36] SAKUMOTO H, YOKOTA Y, ISHIBASHI G, et al. Sinomenine and magnoflorine, major constituents of Sinomeni caulis et rhizoma, show potent protective effects against membrane damage induced by lysophosphatidylcholine in rat erythrocytes[J]. J Nat Med, 2015, 69(3):441-448.
[37] YANG H B, YIN P H, SHI Z, et al. Sinomenine, a COX-2 inhibitor, induces cell cycle arrest and inhibits growth of human colon carcinoma cells in vitro and in vivo[J]. Oncol Lett, 2016, 11(1):411-418.
[38] CHEN D P, WONG C K, LEUNG P C, et al. Anti-inflammatory activities of Chinese herbal medicine sinomenine and Liang Miao San on tumor necrosis factor-α-activated human fibroblast-like synoviocytes in rheumatoid arthritis[J]. J Ethnopharmacol, 2011, 137(5):457-468.
[39] GAO G L, LIANG X L, MA W Y. Sinomenine restrains breast cancer cells proliferation, migration and invasion via modulation of miR-29/PDCD-4 axis[J]. Artif Cells Nanomed Biotechnol, 2019, 47(1):3839-3846.
[40] XU Y T, JIANG T, WANG C H, et al. Sinomenine hydrochloride exerts antitumor outcome in ovarian cancer cells by inhibition of long non-coding RNA HOST2 expression[J]. Artif Cells Nanomed Biotechnol, 2019, 47(1):4131-4138.
[41] LÜ Y, LI C, LI S, et al. Sinomenine inhibits proliferation of SGC-7901 gastric adenocarcinoma cells via suppression of cyclooxygenase-2 expression[J]. Oncol Lett, 2011, 2(4):741-745.
[42] XU F, LI Q, WANG Z Y, et al. Sinomenine inhibits proliferation, migration, invasion and promotes apoptosis of prostate cancer cells by regulation of miR-23a[J]. Biomed Pharmacother, 2019, 112(1):108592.
[43] ZHU S L, CHEN D Z, LI Y, et al. The latest research progress of sinomenine[J]. J Jishou Univ(Nat Sci Ed)(吉首大学学报:自然科学版), 2011, 32(5):95-100.
[44] MO Z X, ZHOU J Y. Effects of Caulis Sinomenii and sinomenine on morphine-induced place preference and brain histamine level in mice[J]. Pharmacol Clin Chin Mater Med(中药药理与临床), 2006, 22(1):20-22.
[45] ZHANG Y S, HAN J Y, IQBAL O, et al. Research advances and prospects on mechanism of sinomenin on histamine release and the binding to histamine receptors[J]. Int J Mol Sci, 2018, 20(1):70-85.
[46] ZHENG X J, REN L W, LI W, et al. Research progress on the safety of Caulis Sinomenii[J]. Her Med(医药导报), 2019, 38(11):1430-1433.
[47] ZHU W L, ZHANG Y A, HUANG Y J, et al. Chinese herbal medicine for the treatment of drug addiction[J]. Int Rev Neurobiol, 2017, 135(2):279-295.
[48] CAI H B, MO Z X, LI X. Effects of sinomenine on withdrawal response of morphine dependent model in vitro and in vivo[J]. Beijing J Tradit Chin Med(北京中医药), 2008, 27(8):652-655.
[49] LIU Z, ZHENG J F, HU B, et al. The effect of sinomenine on nNOS activity of brain tissues in morphine dependentand withdrawal mice[J]. Chin J Appl Physiol(中国应用生理学杂志), 2007, 23(3):297-299.
[50] FANG M, LI J K, ZHU D Q, et al. Effect of sinomenine on the morphine-dependence and related neural mechanisms in mice[J]. Neurochem Res, 2017, 42(12):3587-3596.
[51] YANG H F, WANG J, CHEN X L, et al. Effects of sinomenine in LPS-associated diseases are related to inhibition of LBP, Mac-1, and L-selectin levels[J]. J Vet Pharmacol Ther, 2019, 42(6):732-737.
[52] GAO Z X, LIN Y C, ZHANG P, et al. Sinomenine ameliorates intervertebral disc degeneration via inhibition of apoptosis and autophagy in vitro and in vivo[J]. Am J Transl Res, 2019, 11(9):5956-5966.
[53] LIU S B, XU S L, WANG Z J, et al. Anti-depressant-like effect of sinomenine on chronic unpredictable mild stress-induced depression in a mouse model[J]. Med Sci Monit, 2018, 24:7646-7653.
[54] LIU Z G, WANG Y Y. Research progress on extraction technology and analysis method of sinomenine from sinomenine[J]. Lishizhen Med Mater Med Res(时珍国医国药), 2006, 17(5):831-832.
[55] WANG X L, WEN P H, FENG L M. Optimization of extraction process of sinomenine[J]. Chin Tradit Herb Drugs(中草药), 2001, 32(8):33-34.
[56] PAN L M. CHEN D D, DONG J, et al. The effect of sinomenine single extraction and other drugs on the extraction rate of sinomenine[J]. Chin Tradit Herb Drugs(中草药), 2003, 34(12):44-46.
[57] KANG H Y, REN L P. Study on the extraction technology of sinomenine from sinomenine[J]. J Anhui Agric Sci(安徽农业科学), 2010, 38(9):4578-4582.
[58] FANG D R, ZHANG Z. The extraction and purification process of Qing Feng Teng in the compound Qufeng sustained-release tablets[J]. J Hubei Univ Chin Med(湖北中医药大学学报), 2011, 13(6):28-30.
[59] WU Z Q, GUO J M, CHEN Q H, et al. Analysis of total alkaloids in Sinomenium acutum by gas chromatography-mass spectrometry[J]. Her Med(医药导报), 2012, 31(4):495-497.
[60] PAN W J, LI X N, ZHANG Z T, et al. Extraction sinomenine from the roots of Sinomenium actum by the method of ultrasonic wave[J]. Nat Prod Res Dev(天然产物研究与开发), 2003, 15(2):127-129.
[61] LI Y L, CHEN J H, WANG Y. Optimization of microwave extraction of sinomenine from sinomenine by star point design response surface method[J]. Lishizhen Med Mater Med Res(时珍国医国药), 2013, 24(3):659-661.
[62] LI X R, LI X Y, ZHOU Y X, et al. Development of patch and spray formulations for enhancing topical delivery of sinomenine hydrochloride[J]. J Pharm Sci, 2010, 99(4):1790-1799.
[63] LIN J J, WANG Y, XIE B, et al. Bioequivalence study of sinomenine patch by microdialysis[J]. China J Chin Mater Med(中国中药杂志), 2008, 33(21):2482-2485.
[64] YANG Y G. Design and evaluation of sinomenine pressure sensitive adhesive dispersive patch[D]. Shenyang: Shenyang Pharmaceutical University, 2008.
[65] ZHANG Q, LIU T, PENG H, et al. Study on the preparation and transdermal absorption of sinomenine[J]. Smart Health(智慧健康), 2018, 4(16):19-21.
[66] CHEN Y. Extraction of ostrich oil and its penetration promoting effect on Sinomenine[D]. Hangzhou: Zhejiang University, 2014.
[67] SONG J, BI H, XIE X, et al. Preparation and evaluation of sinomenine hydrochloride in situ gel for uveitis treatment[J]. Int Immunopharmacol, 2013, 17(1):99-107.
[68] WANG Y, CONG Z N, LIU Q F, et al. Formulation optimization and preparation of sinomenine liposomes[J]. China J Chin Mater Med(中国中药杂志), 2009, 34(3):275-278.
[69] SONG Y L. Preparation and in vitro transdermal behavior of sinomenine hydrochloride and liposome hydrogel paste[D]. Xi'an: Northwest University, 2014.
[70] HAN T F. Preparation of sinomenine hydrochloride ethosomes and its transdermal release under electroporation[D]. Xi'an: Northwest University, 2013.
[71] WANG L S, ZHANG S, LIU L P, et al. Preparation and in vitro transdermal properties of sinomenine microemulsion-based gel[J]. Tradit Chin Drug Res Clin Pharm(中药新药与临床药理), 2011, 22(1):21-24.
[72] ZHANG X Z, CHEN X Q, ZHU H D, et al. Study on the transdermal penetration of sinomenine microemulsion and gel[J]. Chin J Mod App Pharm(中国现代应用药学), 2008, 25(6):518-520.
[73] WU X X, CAO Y J, GUI S Y. Preparation of self soluble microneedles and its effect on transdermal properties of sinomenine hydrochloride gel[J]. Anhui Med Pharm J(安徽医药), 2015, 19(6):1035-1038.
[74] GUO L C, DU L Y, HAO H J, et al. Hydrogel matrix sustained-release tablets of sinomenine-solid lipid nanoparticles: preparation and prescription optimization[J]. Chin J Hosp Pharm(中国医院药学杂志), 2018, 38(18):1893-1897.
[75] ZHANG F. Preparation and properties of sinomenine microcapsules loaded with polylactide by phase inversion method[D]. Tianjin: Tiangong University, 2016.
[76] DENG Y P, XIAO Y Y, PIN Q N, et al. Combined system of sinomenine hydrochloride sustained-release pellets[J]. J Chin Pharm Univ(中国药科大学学报), 2009, 40(3):222-226.
[77] LIAN Y F, ZHENG C Y, ZHU J B, et al. Preparation of sinomenine hydrochloride enteric-coated and sustained-release pellets[J]. Pharm Clin Res(药学与临床研究), 2013, 21(3):218-220.
[78] GAO Q, CHEN J Y, LIU W G. Study on stability of sinomenine hydrochloride hyaluronic acid composite gel for injection injection[J]. J Shandong Med Coll(山东医学高等专科学校学报), 2018, 40(3):167-169.
[79] GUO L H, HUANG X J, CHEN Y Z, et al. Preparation of sinomenine hydrochloride sustained-release microspheres thermosensitive gel[J]. Food and Drug(食品与药品), 2016, 18(2):77-82.
[80] WEI H H, LI S S, HAN T, et al. Preparation and characterization of sinomenine hydrochloride nanoparticle thermosensitive gel for intra articular injection[J]. Chin Tradit Herb Drugs(中草药), 2013, 44(14):1899-1904.
[81] LU X H. Experimental study of sinomenine hydrochloride eye drops on the prevention and treatment of acute rejection of corneal transplantation in rats[A]. The Ninth National Congress of ocular surface and keratology and the second International Symposium on keratology: Hangzhou: Zhejiang Science and Technology Association, 2006.
[82] SONG J K, BI H S, GUO J G, et al. Effect of borneol on corneal permeability of Sinomenine Hydrochloride Eye Drops[J]. Lishizhen Med Mater Med Res(时珍国医国药), 2013, 24(6):1321-1323.
[83] HUANG J. Clinical efficacy and safety evaluation of Qingre Chubi Decoction in treating acute gout[J]. Elect J Clin Med Liter(临床医药文献电子杂志), 2018, 5(62):21.
[84] LAO B N, SUN W F, LI J. Clinical efficacy and safety evaluation of Qingre Chubi Decoction in treating acute gout[J]. J Guangzhou Univ Tradit Chin Med(广州中医药大学学报), 2016, 33(6):794-799.
[85] LI H Y. Clinical efficacy and safety evaluation of Qingre Chubi Decoction in treating acute gout[J]. Clin J Chin Med(中医临床研究), 2018, 10(8):129-130.
[86] XI H Q. Clinical efficacy and safety evaluation of Qingre Chubi Decoction in treating acute gout[J]. Clin Med(临床医学), 2017, 37(8):117-119.
[87] XU W, SUN W F, LI W, et al. Clinical study on the treatment of acute gouty arthritis with Qingre Chubi Decoction[J]. J Emer Tradit Chin Med(中国中医急症), 2014, 23(12):2159-2160,2166.
[88] WANG W Y, MA Z Y, XIONG Y Y, et al. Theoretical analysis on the treatment of rheumatism with Tenglong Decoction[J]. Rheu Arth(风湿病与关节炎), 2019, 8(1):63-65.
[89] SU W, LI J W. Tenglong Decoction and Taohong Siwu Decoction in the treatment of 30 cases of rheumatoid arthritis[J]. Rheu Arth(风湿病与关节炎), 2014, 3(5):5-9.
[90] LI X, LIN Y, CHEN X J, et al.Clinical effect of Qingfu Juanbi Decoction on rheumatoid arthritis[J]. China J Tradit Chin Med Pharm(中华中医药杂志), 2019, 34(1):403-407.
[91] YANG X F, WANG Y C, ZHANG Y D, et al. Study on the effect of different extraction methods of modified Siwushiteng Decoction on acute gouty arthritis in rats[J]. Chin J Exp Tradit Med Form(中国实验方剂学杂志), 2014, 20(7):147-151.
[92] HUI W Q, WANG X X, WANG J L, et al. Research progress in natural components, clinical application and adverse reactions of sinomenia[J]. J Mod Med Health(现代医药卫生), 2019, 35(19):2989-2993.
[93] FANG Q, XIONG H, LU X L, et al. 30 cases of acute gouty arthritis treated by Juanbilijieqing fang and Zhengqingfengtongning[J]. Hunan J Tradit Chin Med(湖南中医杂志), 2018, 34(6):62-64.
[94] XU M M, LIU S F, WAN R J, et al. Combined treatment with sinomenine and acupuncture on collagen-induced arthritis through the NF-κB and MAPK signaling pathway[J]. Oncol Lett, 2018, 15(6):8770-8776.
[95] HUANG R Y, PAN H D, WU J Q, et al. Comparison of combination therapy with methotrexate and sinomenine or leflunomide for active rheumatoid arthritis: a randomized controlled clinical trial[J]. Phytomedicine, 2019, 57(12):403-410.
[96] LIU Y, LIU C Q, TAN T, et al. Sinomenine sensitizes human gastric cancer cells to cisplatin through negative regulation of PI3K/AKT/Wnt signaling pathway[J]. Anticancer Drugs, 2019, 30(10):983-990.
[97] FENG S, ZHU L J, HUANG Z S, et al. Controlled release of optimized electroporation enhances the transdermal efficiency of sinomenine hydrochloride for treating arthritis in vitro and in clinic[J]. Drug Des Devel Ther, 2017, 11:1737-1752.
[98] XU L, LI Y Q, YAO W W, et al. Study on the mechanism of RC membrane permeation of 7 alkaloids of traditional Chinese medicine, such as berberine[J]. China J Chin Mater Med(中国中药杂志), 2018, 43(19):3876-3883.
[99] CAO Y T, PAN L M, ZHU H X, et al. The research of different molecular membrane gradient purificate Qingluotongbi Decoction[J]. World Sci-Tech R&D(世界科技研究与发展), 2009, 31(6):1000-1002.
[100] LIU B, JIANG H L, SHEN B, et al. Supercritical fluid extraction of sinomenine from Sinomenium acutum (Thumb) Rehd et Wils[J]. J Chromatogr A, 2005, 1075(4):213-215.
[101] FENG Z L, CHEN D J, JI X H, et al. Optimal parameters with response surface methodology for supercritical CO₂ extraction of sinomenine[J]. Comput Appl Chem(计算机与应用化学), 2010, 27(7):928-932.
[102] LI X Z, ZHAO Q J, DONG J X, et al. Research progress in the structural modification of sinomenine[J]. J Pharm Pract(药学实践杂志), 2018, 36(3):204-209,214.
[103] TIAN S S, ZHANG R, YANG F Y, et al. Synthesis and anti-inflammatory effect of sinomenine-4-hydroxy-palmitate[J]. J Cell Mol Immunol(细胞与分子免疫学杂志), 2014, 30(3):262-265.
[104] YAN L C, BI E G, LOU Y T, et al. Novel sinomenine derivative 1032 improves immune suppression in experimental autoimmune encephalomyelitis[J]. Biochem Biophys Res Commun, 2010, 391(12):1093-1098.
[105] LI X Z. Synthesis and in vitro anti-inflammatory activity of aryl substituted sinomenine derivatives[D]. Hefei: Anhui Medical University, 2019.
[106] LIU J, LI D W, CAO X K, et al. Preparation and characterization of hyaluronic acid sinomenine conjugates[J]. Chin Pharm J(中国药学杂志), 2015, 50(20):1816-1821.
[107] SU X L, LV H X, JIANG Y Y, et al. Synthesis and identification of sinomenine derivative 4edb and its therapeutic effect on experimental autoimmune myocarditis[J]. J Shanghai Jiaotong Univ Med Sci(上海交通大学学报:医学版), 2017, 37(4):453-457.
[108] PAN H M, LU T, WU X D, et al. Design and synthesis of sinomenine isoxazole derivatives via 1,3-dipolar cycloaddition reaction[J]. Nat Prod Res, 2019. DOI: 10.1080/14786419.2019.1677649.
[109] CHEN H Q, ZHANG W, YANG N, et al. Chitosan-based surface molecularly imprinted polymer microspheres for sustained release of sinomenine hydrochloride in aqueous media[J]. Appl Biochem Biotechnol, 2018, 185(2):370-384.
[110] FERNANDEZ G R, LALATSA A, STATTS L, et al. Transferosomes as nanocarriers for drugs across the skin: quality by design from lab to industrial scale[J]. Int J Pharm, 2019. DOI:10.1016/j.ijpharm.2019.118817.
[111] CHU X Q, WANG X Q, TIAN C L, et al. Dual drug-loaded cubic liquid crystal gels for transdermal delivery: inner structure and percutaneous mechanism evaluations[J]. Drug Dev Ind Pharm, 2019, 45(12):1879-1888.
[112] SONG H, WEN J, LI H, et al. Enhanced transdermal permeability and drug deposition of rheumatoid arthritis via sinomenine hydrochloride-loaded antioxidant surface transethosome[J]. Int J Nanomed, 2019, 14:3177-3188.
[113] LIANG X, CHEN Y L, WU L, et al. In situ hexagonal liquid crystal for intra-articular delivery of sinomenine hydrochloride[J]. Biomed Pharmacother, 2019, 117:108993.
[114] YUAN J C. A case of serious adverse reactions caused by overdose of sinomenine[J]. China J Chin Mater Med(中国中药杂志), 2004, 29(11):71.
[115] LIAO Y C. Analysis of 3 cases of rare systemic acute urticaria caused by large dose sinomenine[J]. Qinghai Med J(青海医药杂志), 2014, 44(1):22.
[116] SHOU D W, HE H Y. Clinical analysis and preventive strategy of 32 cases of drug eruption caused by Zhengqingfengtongning[J]. J Zhejiang Chin Med Univ(浙江中医药大学学报), 2006, 30(5):484.
[117] LI C H. 7 cases of drug eruption caused by Zhengqingfengtongning sustained release tablets[J]. Strait Pharm J(海峡药学), 2008, 20(12):167.
[118] LI H G, YAN S M, DU D H, et al. Literature research of the adverse reactions of Zhengqinfengtongning Injection and its synergism and toxicity reducing effects[J]. Chin Pharm J(中国药学杂志), 2017, 52(2):96-99.
[119] TENG J, XU L, WANG X W, et al. Study on the compatible stability of Zhengqingfengtongning injection and 12 kinds of drugs[J]. Guid J Tradit Chin Med Pharm(中医药导报), 2019, 25(15):49-52.
[120] XIE Y Y, LONG H Y, PENG N C, et al. Preliminary study on compatibility rationality of sodium bisulfite in Zhengqing Fengtongning Injection[J]. China Pharm(中国药师), 2017, 20(5):940-943.
[121] YING Z H, QIU M F. Adverse reactions and preventive strategies of Zhengqingfengtongning[J]. Zhejiang J Integr Tradit Chin West Med(浙江中西医结合杂志), 2005, 15(8):474-475.
[122] CHEN T B, LI D, QIU P, et al. Determination of residual chloroform in raw materials of Zhengqing Fengtongning by headspace GC-ECD method[J]. Chin J Pharm Anal(药物分析杂志), 2015, 35(9):1645-1648.
[123] GUO L W, XING W H, ZHU H X, et al. “Green manufacture” characteristics and national strategic demand of Chinise materia medica membrane technology and its key scientific problems and countermeasures[J]. Chin Tradit Herb Drugs(中草药), 2017, 48(16):3267-3279.